CN Stock MarketDetailed Quotes
300016 Beijing Beilu Pharmaceutical
- 6.23
- +0.12+1.96%
Market Closed Oct 18 15:00 CST
3.06BMarket Cap-49444P/E (TTM)
6.33High6.07Low218.90KlotVolume6.07Open6.11Pre Close135.47MTurnover4.46%Turnover RatioLossP/E (Static)491.94MShares8.9352wk High1.97P/B3.06BFloat Cap3.5852wk Low7.33Limit Up491.18MShs Float43.97Historical High4.89Limit Down4.26%Amplitude1.91Historical Low--Dividend TTM6.19Avg Price98.42KlotAsk--Div YieldTTM100Lot Size118.17KlotBid
Beijing Beilu Pharmaceutical Key Stats
All
YOY
| (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | 21.35%530.8M | 13.96%245.23M | 1.89%886.21M | 4.94%663.15M | -5.08%437.42M | -0.88%215.18M | -8.26%869.74M | -15.68%631.91M | -3.99%460.85M | -6.33%217.1M |
| Refunds of taxes and levies | -20.16%4.61M | -66.19%1.1M | -54.92%5.63M | -48.43%5.77M | 311.12%5.77M | --3.26M | -41.11%12.49M | -32.28%11.19M | -86.09%1.4M | ---- |
| Cash received relating to other operating activities | 68.49%15.81M | -12.23%5.86M | 50.24%29.14M | -77.76%15.25M | -69.33%9.38M | -42.03%6.68M | -71.93%19.4M | 196.93%68.56M | 255.14%30.6M | 204.69%11.51M |
| Cash inflows from operating activities | 21.80%551.22M | 12.03%252.19M | 2.15%920.99M | -3.86%684.17M | -8.17%452.57M | -1.53%225.12M | -13.17%901.63M | -9.81%711.66M | -1.17%492.85M | -3.54%228.62M |
| Goods services cash paid | 8.86%165.97M | 13.26%91.49M | 16.21%375.45M | 4.88%258.64M | -26.31%152.46M | -24.91%80.78M | -3.77%323.08M | 6.03%246.6M | 63.56%206.88M | 37.71%107.58M |
| Staff behalf paid | 11.61%114.3M | 17.33%62.95M | 13.87%199.69M | 16.53%149.01M | 19.69%102.41M | 18.02%53.66M | 10.45%175.36M | 7.79%127.87M | 5.53%85.56M | 8.47%45.46M |
| All taxes paid | -4.54%28.48M | -3.86%12.02M | -33.82%50.8M | -22.87%39.01M | -21.39%29.84M | -22.27%12.5M | -8.84%76.76M | -34.47%50.57M | -33.69%37.96M | -6.79%16.09M |
| Cash paid relating to other operating activities | 6.90%119.9M | 19.01%50.38M | 19.12%236.6M | -8.06%176.29M | 5.56%112.15M | 11.07%42.33M | -43.41%198.61M | -8.06%191.74M | -19.09%106.24M | -27.43%38.11M |
| Cash outflows from operating activities | 8.01%428.66M | 14.57%216.84M | 11.46%862.53M | 1.00%622.94M | -9.11%396.86M | -8.67%189.27M | -16.76%773.82M | -3.16%616.78M | 10.23%436.65M | 9.18%207.24M |
| Net cash flows from operating activities | 120.02%122.56M | -1.40%35.34M | -54.26%58.46M | -35.47%61.23M | -0.88%55.71M | 67.68%35.85M | 17.55%127.81M | -37.64%94.88M | -45.21%56.2M | -54.71%21.38M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | ---- | ---- | 217.48%4.29M | 183.60%3.83M | 111.61%2.18M | -42.28%591.83K | 56.34%1.35M | 138.86%1.35M | 82.26%1.03M | 81.21%1.03M |
| Cash received from returns on investments | 168.14%6.99M | 576.30%4.74M | -67.39%4.04M | -50.99%2.92M | -45.39%2.61M | 74.12%700.26K | 4.69%12.38M | 44.12%5.96M | 15.70%4.77M | 8.69%402.18K |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | -55.28%4.61M | 58.76%4.61M | 207,576.78%21.96M | 97,472.74%10.32M | --10.3M | --2.9M | -93.80%10.58K | -93.74%10.58K | ---- | ---- |
| Cash received relating to other investing activities | 36.97%562M | -8.70%210M | -37.07%736.3M | -24.47%430.3M | -27.08%410.3M | 2,200.00%230M | -40.06%1.17B | -33.45%569.7M | -32.54%562.63M | -66.67%10M |
| Cash inflows from investing activities | 34.84%573.6M | -6.34%219.34M | -35.24%766.59M | -22.47%447.37M | -25.17%425.39M | 1,949.38%234.19M | -39.75%1.18B | -32.97%577.03M | -32.22%568.44M | -63.06%11.43M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -22.00%47.01M | -38.83%18.12M | 40.69%144.61M | 39.81%104.62M | 55.14%60.27M | 33.73%29.63M | -30.44%102.78M | -39.43%74.83M | -50.89%38.85M | -46.08%22.15M |
| Net cash paid to acquire subsidiaries and other business units | --148.61M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash paid relating to other investing activities | 86.32%839M | 19.42%490M | -37.53%736.3M | -53.19%450.3M | -42.13%450.3M | -21.02%410.3M | -39.12%1.18B | -22.97%962.05M | -14.86%778.18M | 25.48%519.48M |
| Cash outflows from investing activities | 102.64%1.03B | 15.50%508.12M | -31.26%880.91M | -46.48%554.92M | -37.51%510.57M | -18.78%439.93M | -39.23%1.28B | -24.45%1.04B | -17.73%817.03M | 19.02%541.64M |
| Net cash flows from investing activities | -441.23%-461.02M | -40.37%-288.78M | -16.93%-114.32M | 76.61%-107.55M | 65.73%-85.18M | 61.20%-205.73M | 32.13%-97.76M | 10.12%-459.86M | -60.99%-248.59M | -25.01%-530.21M |
| Financing cash flow | ||||||||||
| Cash from borrowing | -34.45%110M | 20.34%84M | 220.02%323.22M | 97.97%295.52M | 62.48%167.8M | 21.87%69.8M | 56.07%101M | 128.77%149.28M | 273.48%103.28M | --57.28M |
| Cash inflows from financing activities | -34.45%110M | 20.34%84M | 220.02%323.22M | 97.97%295.52M | 62.48%167.8M | 21.87%69.8M | -41.93%101M | 52.58%149.28M | 126.55%103.28M | --57.28M |
| Borrowing repayment | -56.43%63.96M | 620.00%43.2M | 172.72%215.47M | 65.96%202.97M | 165.48%146.8M | --6M | -63.99%79.01M | 2.64%122.3M | -16.85%55.3M | ---- |
| Dividend interest payment | -86.25%5.32M | 16.56%2.45M | 10.28%50.72M | 4.61%42.07M | 1.27%38.73M | 19.58%2.1M | 2.44%45.99M | 11.75%40.22M | 12.10%38.24M | -48.89%1.76M |
| Cash payments relating to other financing activities | -29.78%2.05M | 1,564.16%1.66M | -97.02%3.86M | -97.02%3.86M | -97.73%2.92M | --99.68K | 1,257.88%129.74M | 140.81%129.72M | 296.82%128.55M | ---- |
| Cash outflows from financing activities | -62.15%71.33M | 476.85%47.31M | 6.01%270.05M | -14.83%248.9M | -15.15%188.44M | 366.68%8.2M | -6.98%254.74M | 39.82%292.25M | 66.97%222.09M | -48.89%1.76M |
| Net cash flows from financing activities | 287.33%38.67M | -40.43%36.69M | 134.59%53.17M | 132.61%46.62M | 82.63%-20.64M | 10.95%61.6M | -53.81%-153.74M | -28.60%-142.97M | -35.91%-118.81M | 1,714.65%55.52M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | 558.61%589.82K | 150.45%216.38K | -955.73%-2.52M | -256.02%-569.26K | -194.28%-128.61K | -2,503.06%-428.9K | 258.47%294.7K | 279.35%364.86K | 196.20%136.41K | -160.43%-16.48K |
| Net increase in cash and cash equivalents | -495.48%-299.2M | -99.17%-216.53M | 95.78%-5.21M | 99.95%-271.13K | 83.85%-50.25M | 76.02%-108.72M | 8.90%-123.4M | -7.86%-507.59M | -123.45%-311.07M | -19.18%-453.33M |
| Add:Begin period cash and cash equivalents | -0.71%731.74M | -0.71%731.74M | -14.34%736.94M | -14.34%736.94M | -14.34%736.94M | -14.34%736.94M | -13.60%860.34M | -13.60%860.34M | -13.60%860.34M | -13.60%860.34M |
| End period cash equivalent | -37.01%432.53M | -17.99%515.2M | -0.71%731.74M | 108.83%736.67M | 25.02%686.7M | 54.35%628.23M | -14.34%736.94M | -32.83%352.75M | -35.88%549.27M | -33.87%407.01M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- |
| Auditor | -- | -- | Grant Tung Certified Public Accountants (Special General Partnership) | -- | -- | -- | Grant Tung Certified Public Accountants (Special General Partnership) | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
% Chg
No Data